Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Havel

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer Research|November 28, 2019
MEK Inhibitors in Lung Cancer-You Can Teach an Old Drug New TricksJonathan J Havel
Genome Biology|April 9, 2015
High-resolution genomic analysis: the tumor-immune interface comes into focusJonathan J Havel, Timothy A Chan
Nature Reviews. Cancer|February 14, 2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapyJonathan J Havel, Diego Chowell, Timothy A Chan
International Immunology|April 7, 2016
The role of neoantigens in response to immune checkpoint blockadeNadeem Riaz, Luc Morris, Jonathan J Havel, et al.
Cancer Immunology Research|December 22, 2017
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire AnalysisJohn-William Sidhom, Catherine A Bessell, Jonathan J Havel, et al.
Molecular Cancer Research : MCR|March 6, 2021
Qa-1<sup>b</sup> Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen ProcessingXiao Zhang, Erich Sabio, Chirag Krishna, et al.
Nature Genetics|September 27, 2016
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapyNadeem Riaz, Jonathan J Havel, Sviatoslav M Kendall, et al.
Journal of Molecular Cell Biology|November 19, 2015
Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platformXiu-Lei Mo, Yin Luo, Andrei A Ivanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cellsWen-Chin Huang, Jonathan J Havel, Haiyen E Zhau, et al.
JCI Insight|October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implicationsRajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Research|November 28, 2019
MEK Inhibitors in Lung Cancer-You Can Teach an Old Drug New TricksJonathan J Havel
Genome Biology|April 9, 2015
High-resolution genomic analysis: the tumor-immune interface comes into focusJonathan J Havel, Timothy A Chan
Nature Reviews. Cancer|February 14, 2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapyJonathan J Havel, Diego Chowell, Timothy A Chan
International Immunology|April 7, 2016
The role of neoantigens in response to immune checkpoint blockadeNadeem Riaz, Luc Morris, Jonathan J Havel, et al.
Cancer Immunology Research|December 22, 2017
ImmunoMap: A Bioinformatics Tool for T-cell Repertoire AnalysisJohn-William Sidhom, Catherine A Bessell, Jonathan J Havel, et al.
Molecular Cancer Research : MCR|March 6, 2021
Qa-1<sup>b</sup> Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen ProcessingXiao Zhang, Erich Sabio, Chirag Krishna, et al.
Nature Genetics|September 27, 2016
Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapyNadeem Riaz, Jonathan J Havel, Sviatoslav M Kendall, et al.
Journal of Molecular Cell Biology|November 19, 2015
Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platformXiu-Lei Mo, Yin Luo, Andrei A Ivanov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cellsWen-Chin Huang, Jonathan J Havel, Haiyen E Zhau, et al.
JCI Insight|October 26, 2016
The head and neck cancer immune landscape and its immunotherapeutic implicationsRajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard, et al.
Pageof 2